Torill Tangen
Overview
Explore the profile of Torill Tangen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Norheim G, Aseffa A, Yassin M, Mengistu G, Kassu A, Fikremariam D, et al.
Clin Vaccine Immunol
. 2008 Mar;
15(5):863-71.
PMID: 18337382
Dissecting the specificities of human antibody responses following disease caused by serogroup A meningococci may be important for the development of improved vaccines. We performed a study of Ethiopian patients...
2.
Norheim G, Aseffa A, Yassin M, Mengistu G, Kassu A, Fikremariam D, et al.
Clin Vaccine Immunol
. 2007 Feb;
14(4):451-63.
PMID: 17301215
To elucidate critical components of protective immune responses induced during the natural course of serogroup A meningococcal disease, we studied acute-, early-convalescent-, and late-convalescent-phase sera from Ethiopian patients during outbreaks...
3.
Norheim G, Aase A, Caugant D, Hoiby E, Fritzsonn E, Tangen T, et al.
Vaccine
. 2005 May;
23(29):3762-74.
PMID: 15893613
Neisseria meningitidis bacteria of serogroup A are causing recurring meningitis epidemics on the African continent. An outer membrane vesicle (OMV) vaccine against serogroup A meningococci made from a subgroup III...
4.
Norheim G, Hoiby E, Caugant D, Namork E, Tangen T, Fritzsonn E, et al.
Vaccine
. 2004 May;
22(17-18):2171-80.
PMID: 15149774
Serogroup A Neisseria meningitidis organisms of the subgroup III have caused epidemics of meningitis in sub-Saharan Africa since their introduction into the continent in 1987. The population structure of these...